Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing Providers' knowledge about and barriers to lung cancer screening.
Quezada JJ, Avenido AR, Jia S, Bernaba A, Nguyen S, Gharagozlou SS, Nguyen TQ, Keshava H, Sadigh G. Quezada JJ, et al. Among authors: keshava h. Cancer Treat Res Commun. 2024 Nov 15;41:100850. doi: 10.1016/j.ctarc.2024.100850. Online ahead of print. Cancer Treat Res Commun. 2024. PMID: 39577140 Free article.
Elastofibroma Dorsi: Case Series of a Rare Chest Wall Pseudotumor.
Chase LM, Sedighim S, Lee C, Hegazi M, Keshava HB, Mahtabifard A. Chase LM, et al. Among authors: keshava hb. World J Surg. 2023 Oct;47(10):2587-2593. doi: 10.1007/s00268-023-07086-2. Epub 2023 Jun 23. World J Surg. 2023. PMID: 37353714
Sins of omission: A meta-research study evaluating the omission of operability in published retrospective comparisons of surgery with stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer.
Lorenz J, Moghanaki D, Keshava H, Harpole DH, Bradley JD, Higgins KA, Rusthoven CG Jr, Stokes WA. Lorenz J, et al. Among authors: keshava h. Lung Cancer. 2023 Jan;175:57-59. doi: 10.1016/j.lungcan.2022.11.011. Epub 2022 Nov 19. Lung Cancer. 2023. PMID: 36455397
Controversies in Lung Cancer: Heterogeneity in Treatment Recommendations for Stage III NSCLC According to Disease Burden and Oncogenic Driver Alterations.
Harris JP, Fujimoto DK, Nagasaka M, Ku E, Harada G, Keshava H, Mahtabifard A, Longoria J, Patel N, Seyedin S, Simon A, Chen A. Harris JP, et al. Among authors: keshava h. Clin Lung Cancer. 2022 Jun;23(4):333-344. doi: 10.1016/j.cllc.2022.02.001. Epub 2022 Feb 10. Clin Lung Cancer. 2022. PMID: 35256282 Free article.
Long-term assessment of efficacy with a novel Thoracic Survivorship Program for patients with lung cancer.
Keshava HB, Tan KS, Dycoco J, Huang J, Berkowitz A, Sumner D, Devigne A, Adusumilli P, Bains M, Bott M, Isbell J, Downey R, Molena D, Park B, Rocco G, Sihag S, Jones DR, Rusch VW. Keshava HB, et al. J Thorac Cardiovasc Surg. 2022 May;163(5):1645-1653.e4. doi: 10.1016/j.jtcvs.2021.11.026. Epub 2021 Nov 20. J Thorac Cardiovasc Surg. 2022. PMID: 34922758 Free PMC article.
27 results